Radar · Industry landscape · the United States
Age Tech and Longevity Industry Landscape of the United States 1,115 Age Tech and Longevity companies in the United States, in one picture: who is hiring, who is raising money, who founded them, where they are based, which skills employers want and where the research is going. Updated September 2026.
1,115 companies tracked
$7.5B disclosed funding
61 hiring right now
220 events · 24 months
Who leads Age Tech and Longevity in the United States Shows 1,115 U.S. Age Tech and Longevity firms, highlighting which are hiring, best funded, and currently hiring, with 61 firms hiring now and 260 having disclosed funding rounds.
Radar
See all 1,115 Age Tech and Longevity companies in the United States
Filter by funding, headcount, hiring and location, and export the list.
How the Age Tech and Longevity ecosystem in the United States grew, 2016–2025 Displays the number of companies founded each year, peaking at 97 in 2020 and falling to 11 in 2025.
Companies founded / year
new Age Tech and Longevity companies in the United States
2016: 57 2017: 75 2018: 82 2019: 88 2020: 97 2021: 65 2022: 53 2023: 38 2024: 24 2025: 11 2016 2025
peak 97 in 2020
Companies raising / year
with a disclosed round that year
2016 2025
peak 55 in 2020
Disclosed funding / year
sum of disclosed rounds (USD)
2016: 158,962,926 2017: 136,580,711 2018: 1,010,953,926 2019: 327,099,997 2020: 585,206,621 2021: 1,534,315,912 2022: 957,437,015 2023: 453,791,795 2024: 651,638,402 2025: 826,216,988 2016 2025
peak $1.5B in 2021
Where Age Tech and Longevity companies in the United States are based → Hub 01
New York City
74 Age Tech and Longevity companies
29% of the Age Tech and Longevity companies across these hubs
74 companies
$733.2M disclosed funding
4 hiring now
Hub 02
San Francisco
65 Age Tech and Longevity companies
25% of the Age Tech and Longevity companies across these hubs
65 companies
$1.2B disclosed funding
7 hiring now
Hub 03
Los Angeles
26 Age Tech and Longevity companies
10% of the Age Tech and Longevity companies across these hubs
26 companies
$112M disclosed funding
2 hiring now
Hub 04
Seattle
23 Age Tech and Longevity companies
9% of the Age Tech and Longevity companies across these hubs
23 companies
$240.1M disclosed funding
3 hiring now
Hub 05
Austin
20 Age Tech and Longevity companies
8% of the Age Tech and Longevity companies across these hubs
20 companies
$154M disclosed funding
1 hiring now
Hub 06
Chicago
16 Age Tech and Longevity companies
6% of the Age Tech and Longevity companies across these hubs
16 companies
$19M disclosed funding
Hub 07
Houston
16 Age Tech and Longevity companies
6% of the Age Tech and Longevity companies across these hubs
16 companies
$7.8M disclosed funding
Hub 08
Boston
15 Age Tech and Longevity companies
6% of the Age Tech and Longevity companies across these hubs
15 companies
$67M disclosed funding
2 hiring now
The Age Tech and Longevity market map of the United States: what these companies actually do Consumer Digital 802 companies · $3.3B raised · 39 hiring Healthtech 517 companies · $3.5B raised · 36 hiring Enterprise Tech 448 companies · $4.8B raised · 29 hiring B2C E-Commerce 242 companies · $2.1B raised · 22 hiring IoT in Healthcare 202 companies · $1.1B raised · 10 hiring Medical Devices 198 companies · $1.1B raised · 10 hiring Fintech 183 companies · $2.1B raised · 11 hiring Enterprise Software 178 companies · $1.9B raised · 14 hiring Loneliness Economy 176 companies · $1.8B raised · 13 hiring Consumer Internet of Things 171 companies · $397.2M raised · 7 hiring Chronic Disease Management 166 companies · $1.3B raised · 11 hiring SaaS 162 companies · $1.3B raised · 8 hiring Monetization
How Age Tech and Longevity companies make money How many companies earn revenue each way. Plenty use more than one model, so the counts add up to more than the sector.
Subscription 738
Commission on Transaction 310
Fee-For-Service 192
E-Commerce - Product 156
Advertising 148
E-Commerce - Service 124
Physical Commerce 104
Sponsorship 13
Funding, M&A and the deals moving Age Tech and Longevity in the United States Funding 52 Earnings 48 Leadership 47 M&A 24 Product 17 Announcement 15 Contracts 6 Capital 4 Funds Raising 3 Incorporation 1
M&A Manhattan Beach-headquartered private equity firm Pacific Avenue Capital Partners announced that an affiliate has entered into an agreement to acquire Care.com, a digital marketplace for caregiving services, from IAC Inc. 2026-04-01 Funding The round was led by Lifeline Ventures, known for backing companies such as Oura, Supercell, and Wolt in their early stages. Additional investors include Tiny VC, Wave Ventures, and First Fellow Partners, alongside several angel investors, including Cal Henderson, the co-founder of Slack. 2026-03-10 Funding Chptr, a storytelling platform helping funeral homes share memorial stories with the communities they serve, has raised $3.25M in funding according to a recent SEC filing. 2026-03-09 M&A Applied Digital plans to combine its cloud computing unit, Applied Digital Cloud, with EKSO. 2025-12-30 M&A LifeVantage and LoveBiome: LifeVantage acquired LoveBiome to expand its gut health portfolio. 2025-12-16 M&A CareScout has announced the acquisition of Seniorly (https://www.seniorly.com/). 2025-11-14 Funding Carepool Innovation Inc., whose medical rideshare platform automates medical transportation, has landed significant new funding from Decathlon Capital Partners. The multi-million-dollar investment package will support the expansion of Carepool into new geographic markets. 2025-10-27 M&A Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ('Telomir' or the 'Company'), a preclinical-stage biotechnology company developing therapies that target epigenetic drivers of cancer, aging, and age-related disease, today announced that it has executed a binding Letter of Intent (the 'LOI') to acquire TELI Pharmaceuticals, Inc. 2025-10-21 Funding DUOS, a leading AI-powered digital health platform for member activation and benefits execution, today announced a $130 million strategic growth equity investment led by FTV Capital, a sector-focused growth equity firm with deep expertise in healthcare technology and services. The investment round also includes participation from Forerunner Ventures, DUOS’ earliest institutional investor, bringing the company full circle as it enters the next phase of growth. 2025-10-14 M&A Last month, Gusto, a payroll and HR software company, announced that it agreed to acquire Guideline, a startup offering retirement plans to small and medium businesses. 2025-10-01 Mergers and acquisitions Deals from the last 24 months where a Age Tech and Longevity company in the United States was the buyer or the one bought, newest first. “Undisclosed” means the price was never published — not that the deal was worth nothing.
Acquirer Target Deal value Status Date baker tillyVanilla undisclosed Announced 2026-05-01 pacific avenue capital partnersCare.com undisclosed Announced 2026-04-01 IAC Inc. Care.com $500M Completed 2026-04-01 affiliate of Pacific Avenue Capital Partners Care.com $320M Announced 2026-03-02 applied digitalEkso Bionics undisclosed Announced 2025-12-30 LifeVantage LoveBiome undisclosed Completed 2025-12-16
Who is listing, hiring leaders, launching and winning work Provides details on IPO filings, leadership changes, product launches and contract wins for companies in the sector.
IPO pipeline
3 companies listed or filing · last 24 months
Contract wins
4 customer wins · last 24 months
Earnings pulse
companies reporting results · last 24 months
5 companies reporting50 company-quarters trackedbeat 8 miss 5 in line 2
Half of these companies grew revenue faster than -3.0% , half slower.
Who is building Age Tech and Longevity in the United States Profiles 754 founders and CEOs across 563 firms, noting top alma maters like Harvard (17) and Stanford (14) and previous employers such as Microsoft (7).
Founders and chief executives 12 of 754, from the best-funded companies on this page
→ repeat founder Co-Founder Comprehensive, ex-Co-Founder Thunder, SubProfile. Harvard University BA 2008
Co-Founder & CEO
Seth Sternberg
Ex -Co-Founder & CEO Meebo, Google. Yale University BA 2001, Stanford University Graduate School of Business MBA 2005
Co-Founder & CEO
Kevin Busque
Ex-Co-Founder TaskRabbit, Humedica, Institute for Health Metrics, Founder LinkedUp. Fitchburg State University 2003…
Upside, ex-Motionpoint, ex-Zudy Software, University of Florida
Ex - President Stadion Money Management, Senior Vice President Lincoln Financial Group. University of Nebraska-Lincoln BS…
Ypo Ny Liberty, ex-Remedy Partners, ex-Complex Care Solutions, New York University - Stern School of Business, 2005
Chief Executive Officer
Tatyana Zlotsky
A Place For Mom, ex-American Express, ex-Comcast, Harvard Business School, 2016
Co-Founder & CEO
Jeffrey Cleland
Ex-Orpheris, Graybug Vision, Founder Versartis, PDMDC, Diartis Pharmaceuticals, BaroFold. University of California, Davis BS 1986, MIT PhD 1991
Co-Founder & Chief Executive Officer
Karl Ulfers
Duos, ex-Stealth Venture, ex-Rally Health, Saint John's University, 1970
repeat founder Ex-WeWork, Aleph VC, eBay, Co-Founder The Gifts Project. Reichman University BA 2010, The Open University of Israel 2001
repeat founder Founder Care, Ohai, ex-TheLadders, Upromise, Putnam Hayes & Bartlett. Mount Holyoke College BA 1993, HBS MBA 1998, Harvard Law School JD 1999
Co-Founder, CPO
David Weisz
Jibe Ventures, ex-Wix, ex-Israeli Navy, The Interdisciplinary Center, 2012
Where the founders studied
alma mater on record for 101 of 754 founders
Harvard University 17
Stanford University 14
Harvard Business School 12
Massachusetts Institute of Technology 7
Columbia University 7
Cornell University 6
University of California (Berkeley) 5
University of Pennsylvania 4
Where they worked before
a previous employer on record for 28 of 754 founders
Microsoft 7
Intel 5
Google 3
Uber 3
McKinsey 2
Facebook 2
Apple 2
eBay 1
Founders flagged as repeat founders
of 591 founders with a profile on this page
7
carry a repeat-founder flag
flagged as repeat founders 7 no repeat-founder flag 584 Women and men among the founders
first names matched for 696 of 754 founders
23%
of matched founders are women
Inferred from first names, using 119 million people who state their own gender: a first name counts only where at least 20 of them share it and at least 90% of those share the same gender. The other 58 founders go in neither column.
Radar
Look up the people behind Age Tech and Longevity companies in the United States
Search founders, executives and operators by company, role and location.
Who funds Age Tech and Longevity in the United States Records 609 funding rounds since 2016 from 708 investors, with an average round size of $2.3 million.
Stage mix · rounds since 2016
Seed & Angel 233
Series A–B 174
Series C+ / PE 47
Grants, debt & other 155
The typical round is $2.3M — half were bigger, half smaller.
The biggest Age Tech and Longevity funding rounds in the United States Highlights the largest disclosed round—Human Interest’s $242 million Series E—and lists ten other large recent rounds.
Company Round Size When Backers Human Interest Series E $242M Mar 2024 Baillie Gifford , Marshall Wace , Morgan Stanley Smart Series D $225.4M Jan 2022 — Guideline Series E $200M Jun 2021 General Atlantic , Generation Investment Management , Greyhound Capital +2 more Human Interest Series D $200M Aug 2021 The Rise Fund , NewView Capital , Wing Venture Capital +8 more A Place for Mom Series B $175M Jan 2022 Insight Partners , General Atlantic , Silver Lake Papa Series D $150M Oct 2021 TCG Ventures , SoftBank Vision Fund , Canaan +3 more Honor Series D $140M Oct 2020 Baillie Gifford , Prosus , Andreessen Horowitz +3 more DUOS Series B $130M Oct 2025 FTV Capital , Forerunner Ventures Human Interest Series E $100M Nov 2025 Morgan Stanley , BlackRock , Baillie Gifford +1 more Character Biosciences Series B $93M Mar 2025 aMoon , Luma Group , Bausch & Lomb +6 more
Venture round sizes · 2023–2025
<$1M 25
$1–10M 44
$10–50M 32
$50–250M 10
>$250M 0
111 venture rounds with a disclosed amount in the window.
Fresh cheques · last 6 months
Age Tech and Longevity jobs in the United States: who is hiring and what they ask for Summarizes 1,049 job postings in the last year from 117 employers, with median pay of $52 k and top‑required skills including lifting, CNA license, Excel, React and CRM.
1,049 postings · last 12 months
2,181 postings tracked overall
117 employers advertising
$52k median advertised salary/yr (n=199)
Demand
The Skills Employers Ask For What Age Tech and Longevity employers in the United States put in their job ads. The bar is how many postings ask for it; the arrow shows whether demand grew or shrank against the year before.
lifting 52 ▲ cna license 50 ▲ excel 21 ▲ react 17 ▲ crm 15 ▲ aws 15 ▲ memory impairment 12 ▲ word 11 ▲ lpn 10 ▲ sql 10 ▲ What level are these roles?
Entry 33
Intern 46
Senior 139
Lead 23
Manager 348
Most advertised titles
Manager 44 Dog Sitter 30 Pet Sitter 30 Graduate Consultant 27 Healthcare Account Executive 27 Caregiver / Home Care Aide 26 What Age Tech and Longevity research in the United States is working on Counts 11,793 U.S. academic papers, of which 1,319 identify common problems, 670 issue cautions, and 7,239 discuss opportunities.
How this field talks about itself
United States-affiliated Age Tech and Longevity papers (gold) against all published research (grey)
Promising 37.9% · 36.9% ≈ par
Breakthrough 23.5% · 26.5% ≈ par
Descriptive 20.1% · 17.6% ≈ par
Problem-identifying 7.7% · 9.7% 0.8×
Cautionary 5.7% · 4.6% 1.2×
Critical 3.5% · 0.9% 3.9×
How the work is done
Empirical 74.1%
Reviews 13.6%
Methods-led 7.6%
Position pieces 3.1%
Theoretical 1.6%
How the research reads
88% positive · 6% neutral · 6% negative , across 11,793 papers.
The institutions doing the work · United States
Buck Institute for Research on Aging 36k Harvard University 31k Lawrence Berkeley National Laboratory 23k Mayo Clinic in Florida 23k Mayo Clinic 18k National Institute on Aging 16k ranked by how often their work is cited
Leading researchers · United States-affiliated work
Judith Campisi · Jean‐Philippe Coppé · Tamar Tchkonia · Pierre‐Yves Desprez · James L. Kirkland · Ana Krtolica · Marco Demaria · Yi Zhu
The most-cited breakthroughs
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor · 4k cites Cellular senescence mediates fibrotic pulmonary disease · 2k cites A proteomic atlas of senescence-associated secretomes for aging biomarker development · 1k cites Fat tissue, aging, and cellular senescence · 1k cites Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity · 968 cites Common problems researchers identify 1,221 papers · 7 recurring themes
→ Problems · theme 01
Immune System / Disease
219 papers · 17.9% of this block
2022: 3,331 of every 10,000 papers on this subject 2023: 3,352 of every 10,000 papers on this subject 2024: 3,155 of every 10,000 papers on this subject 2025: 3,356 of every 10,000 papers on this subject 2022: 3,331 of every 10,000 papers on this subject 2023: 3,352 of every 10,000 papers on this subject 2024: 3,155 of every 10,000 papers on this subject 2025: 3,356 of every 10,000 papers on this subject → +1% share 2022→2025 share of research on this subject Immune system · Disease · Immunosenescence · Neuroscience
“On the Immunological Theory of Aging”
Problems · theme 02
Senescence / Cellular Senescence
216 papers · 17.7% of this block
2022: 1,887 of every 10,000 papers on this subject 2023: 2,121 of every 10,000 papers on this subject 2024: 1,779 of every 10,000 papers on this subject 2025: 1,141 of every 10,000 papers on this subject 2022: 1,887 of every 10,000 papers on this subject 2023: 2,121 of every 10,000 papers on this subject 2024: 1,779 of every 10,000 papers on this subject 2025: 1,141 of every 10,000 papers on this subject ▼ -40% share 2022→2025 share of research on this subject Senescence · Cellular senescence · Cell biology · Phenotype
“Assessing Cell and Organ Senescence Biomarkers”
Problems · theme 03
Gerontology / Longevity
186 papers · 15.2% of this block
2022: 1,861 of every 10,000 papers on this subject 2023: 1,835 of every 10,000 papers on this subject 2024: 2,190 of every 10,000 papers on this subject 2025: 1,419 of every 10,000 papers on this subject 2022: 1,861 of every 10,000 papers on this subject 2023: 1,835 of every 10,000 papers on this subject 2024: 2,190 of every 10,000 papers on this subject 2025: 1,419 of every 10,000 papers on this subject ▼ -24% share 2022→2025 share of research on this subject Gerontology · Longevity · Healthy aging · Psychological intervention
“The Biology of Aging”
Problems · theme 04
Longevity / Longevity Risk
162 papers · 13.3% of this block
2022: 308 of every 10,000 papers on this subject 2023: 287 of every 10,000 papers on this subject 2024: 329 of every 10,000 papers on this subject 2025: 216 of every 10,000 papers on this subject 2022: 308 of every 10,000 papers on this subject 2023: 287 of every 10,000 papers on this subject 2024: 329 of every 10,000 papers on this subject 2025: 216 of every 10,000 papers on this subject ▼ -30% share 2022→2025 share of research on this subject Longevity · Longevity risk · Ecology · Evolutionary biology
“The evolutionary ecology of senescence”
Problems · theme 05
Reproduction / Fecundity
153 papers · 12.5% of this block
2022: 248 of every 10,000 papers on this subject 2023: 225 of every 10,000 papers on this subject 2024: 235 of every 10,000 papers on this subject 2025: 239 of every 10,000 papers on this subject 2022: 248 of every 10,000 papers on this subject 2023: 225 of every 10,000 papers on this subject 2024: 235 of every 10,000 papers on this subject 2025: 239 of every 10,000 papers on this subject ▼ -4% share 2022→2025 share of research on this subject Reproduction · Fecundity · Longevity · Life history theory
“Life histories and the evolution of cooperative breeding in mammals”
Problems · theme 06
Demography / Life Expectancy
145 papers · 11.9% of this block
2022: 2,006 of every 10,000 papers on this subject 2023: 1,969 of every 10,000 papers on this subject 2024: 2,304 of every 10,000 papers on this subject 2025: 1,509 of every 10,000 papers on this subject 2022: 2,006 of every 10,000 papers on this subject 2023: 1,969 of every 10,000 papers on this subject 2024: 2,304 of every 10,000 papers on this subject 2025: 1,509 of every 10,000 papers on this subject ▼ -25% share 2022→2025 share of research on this subject Demography · Life expectancy · Longevity · Gerontology
“Measuring Recent Apparent Declines In Longevity: The Role Of Increasing Educational Attainment”
Problems · theme 07
Longevity / Internal Medicine
140 papers · 11.5% of this block
2022: 3,042 of every 10,000 papers on this subject 2023: 3,310 of every 10,000 papers on this subject 2024: 3,010 of every 10,000 papers on this subject 2025: 1,892 of every 10,000 papers on this subject 2022: 3,042 of every 10,000 papers on this subject 2023: 3,310 of every 10,000 papers on this subject 2024: 3,010 of every 10,000 papers on this subject 2025: 1,892 of every 10,000 papers on this subject ▼ -38% share 2022→2025 share of research on this subject Longevity · Internal medicine · Caloric theory · Insulin
“Different dietary restriction regimens extend lifespan by both independent and overlapping genetic pathways in <i>C. elegans</i>”
Cautions 638 papers · 7 recurring themes
→ Cautions · theme 01
Longevity / Fecundity
168 papers · 26.3% of this block
2022: 961 of every 10,000 papers on this subject 2023: 945 of every 10,000 papers on this subject 2024: 719 of every 10,000 papers on this subject 2025: 546 of every 10,000 papers on this subject 2022: 961 of every 10,000 papers on this subject 2023: 945 of every 10,000 papers on this subject 2024: 719 of every 10,000 papers on this subject 2025: 546 of every 10,000 papers on this subject ▼ -43% share 2022→2025 share of research on this subject Longevity · Fecundity · Population · Juvenile
“Cattle adapted to tropical and subtropical environments: genetic and reproductive considerations”
Cautions · theme 02
Senescence / Cell Biology
106 papers · 16.6% of this block
2022: 2,108 of every 10,000 papers on this subject 2023: 2,335 of every 10,000 papers on this subject 2024: 2,020 of every 10,000 papers on this subject 2025: 1,456 of every 10,000 papers on this subject 2022: 2,108 of every 10,000 papers on this subject 2023: 2,335 of every 10,000 papers on this subject 2024: 2,020 of every 10,000 papers on this subject 2025: 1,456 of every 10,000 papers on this subject ▼ -31% share 2022→2025 share of research on this subject Senescence · Cell biology · Stem cell · Progenitor cell
“Ageing compromises mouse thymus function and remodels epithelial cell differentiation”
Cautions · theme 03
Longevity / Gerontology
102 papers · 16.0% of this block
2022: 2,006 of every 10,000 papers on this subject 2023: 1,969 of every 10,000 papers on this subject 2024: 2,304 of every 10,000 papers on this subject 2025: 1,509 of every 10,000 papers on this subject 2022: 2,006 of every 10,000 papers on this subject 2023: 1,969 of every 10,000 papers on this subject 2024: 2,304 of every 10,000 papers on this subject 2025: 1,509 of every 10,000 papers on this subject ▼ -25% share 2022→2025 share of research on this subject Longevity · Gerontology · Life expectancy · Demography
“Animal Models of Aging Research: Implications for Human Aging and Age-Related Diseases”
Cautions · theme 04
Senescence / Mesenchymal Stem Cell
84 papers · 13.2% of this block
2022: 1,669 of every 10,000 papers on this subject 2023: 2,433 of every 10,000 papers on this subject 2024: 1,563 of every 10,000 papers on this subject 2025: 1,051 of every 10,000 papers on this subject 2022: 1,669 of every 10,000 papers on this subject 2023: 2,433 of every 10,000 papers on this subject 2024: 1,563 of every 10,000 papers on this subject 2025: 1,051 of every 10,000 papers on this subject ▼ -37% share 2022→2025 share of research on this subject Senescence · Mesenchymal stem cell · Cancer research · Cell biology
“Human Obesity Induces Dysfunction and Early Senescence in Adipose Tissue-Derived Mesenchymal Stromal/Stem Cells”
Cautions · theme 05
Longevity / Caenorhabditis Elegans
72 papers · 11.3% of this block
2022: 2,173 of every 10,000 papers on this subject 2023: 2,452 of every 10,000 papers on this subject 2024: 2,115 of every 10,000 papers on this subject 2025: 1,370 of every 10,000 papers on this subject 2022: 2,173 of every 10,000 papers on this subject 2023: 2,452 of every 10,000 papers on this subject 2024: 2,115 of every 10,000 papers on this subject 2025: 1,370 of every 10,000 papers on this subject ▼ -37% share 2022→2025 share of research on this subject Longevity · Caenorhabditis elegans · Drosophila melanogaster · Genetics
“Uncoupling lifespan and healthspan in <i>Caenorhabditis elegans</i> longevity mutants”
Cautions · theme 06
Internal Medicine / Calorie Restriction
72 papers · 11.3% of this block
2022: 3,268 of every 10,000 papers on this subject 2023: 3,524 of every 10,000 papers on this subject 2024: 3,220 of every 10,000 papers on this subject 2025: 2,011 of every 10,000 papers on this subject 2022: 3,268 of every 10,000 papers on this subject 2023: 3,524 of every 10,000 papers on this subject 2024: 3,220 of every 10,000 papers on this subject 2025: 2,011 of every 10,000 papers on this subject ▼ -38% share 2022→2025 share of research on this subject Internal medicine · Calorie restriction · Endocrinology · Caloric theory
“Epigenetic aging signatures in mice livers are slowed by dwarfism, calorie restriction and rapamycin treatment”
Cautions · theme 07
Honey Bee / Pesticide
34 papers · 5.3% of this block
2022: 13 of every 10,000 papers on this subject 2023: 13 of every 10,000 papers on this subject 2024: 13 of every 10,000 papers on this subject 2025: 12 of every 10,000 papers on this subject 2022: 13 of every 10,000 papers on this subject 2023: 13 of every 10,000 papers on this subject 2024: 13 of every 10,000 papers on this subject 2025: 12 of every 10,000 papers on this subject ▼ -7% share 2022→2025 share of research on this subject Honey bee · Pesticide · Imidacloprid · Brood
“Factors affecting the reproductive health of honey bee (Apis mellifera) drones—a review”
Opportunities 6,823 papers · 7 recurring themes
→ Opportunities · theme 01
Senescence / Autophagy
1,130 papers · 18.8% of this block
2022: 3,279 of every 10,000 papers on this subject 2023: 3,550 of every 10,000 papers on this subject 2024: 3,262 of every 10,000 papers on this subject 2025: 2,186 of every 10,000 papers on this subject 2022: 3,279 of every 10,000 papers on this subject 2023: 3,550 of every 10,000 papers on this subject 2024: 3,262 of every 10,000 papers on this subject 2025: 2,186 of every 10,000 papers on this subject ▼ -33% share 2022→2025 share of research on this subject Senescence · Autophagy · Internal medicine · Oxidative stress
“Age-dependent effects of <i>Igf2bp2</i> on gene regulation, function, and aging of hematopoietic stem cells in mice”
Opportunities · theme 02
Senescence / Cell Biology
1,109 papers · 18.5% of this block
2022: 1,887 of every 10,000 papers on this subject 2023: 2,121 of every 10,000 papers on this subject 2024: 1,779 of every 10,000 papers on this subject 2025: 1,141 of every 10,000 papers on this subject 2022: 1,887 of every 10,000 papers on this subject 2023: 2,121 of every 10,000 papers on this subject 2024: 1,779 of every 10,000 papers on this subject 2025: 1,141 of every 10,000 papers on this subject ▼ -40% share 2022→2025 share of research on this subject Senescence · Cell biology · Cellular senescence · Phenotype
“Cellular Senescence and the Biology of Aging, Disease, and Frailty”
Opportunities · theme 03
Senescence / Cell Biology
944 papers · 15.7% of this block
2022: 1,939 of every 10,000 papers on this subject 2023: 2,169 of every 10,000 papers on this subject 2024: 1,827 of every 10,000 papers on this subject 2025: 1,231 of every 10,000 papers on this subject 2022: 1,939 of every 10,000 papers on this subject 2023: 2,169 of every 10,000 papers on this subject 2024: 1,827 of every 10,000 papers on this subject 2025: 1,231 of every 10,000 papers on this subject ▼ -36% share 2022→2025 share of research on this subject Senescence · Cell biology · Mesenchymal stem cell · Inflammation
“Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity”
Opportunities · theme 04
Longevity / Gerontology
906 papers · 15.1% of this block
2022: 2,006 of every 10,000 papers on this subject 2023: 1,969 of every 10,000 papers on this subject 2024: 2,304 of every 10,000 papers on this subject 2025: 1,509 of every 10,000 papers on this subject 2022: 2,006 of every 10,000 papers on this subject 2023: 1,969 of every 10,000 papers on this subject 2024: 2,304 of every 10,000 papers on this subject 2025: 1,509 of every 10,000 papers on this subject ▼ -25% share 2022→2025 share of research on this subject Longevity · Gerontology · Demography · Life expectancy
“The Search for Longevity and Healthy Aging Genes: Insights From Epidemiological Studies and Samples of Long-Lived Individuals”
Opportunities · theme 05
Cancer Research / Cancer
726 papers · 12.1% of this block
2022: 2,019 of every 10,000 papers on this subject 2023: 2,800 of every 10,000 papers on this subject 2024: 1,955 of every 10,000 papers on this subject 2025: 1,640 of every 10,000 papers on this subject 2022: 2,019 of every 10,000 papers on this subject 2023: 2,800 of every 10,000 papers on this subject 2024: 1,955 of every 10,000 papers on this subject 2025: 1,640 of every 10,000 papers on this subject ▼ -19% share 2022→2025 share of research on this subject Cancer research · Cancer · Senescence · Tumor microenvironment
“Therapy-Induced Cellular Senescence: Potentiating Tumor Elimination or Driving Cancer Resistance and Recurrence?”
Opportunities · theme 06
Caenorhabditis Elegans / Longevity
630 papers · 10.5% of this block
2022: 55 of every 10,000 papers on this subject 2023: 50 of every 10,000 papers on this subject 2024: 54 of every 10,000 papers on this subject 2025: 59 of every 10,000 papers on this subject 2022: 55 of every 10,000 papers on this subject 2023: 50 of every 10,000 papers on this subject 2024: 54 of every 10,000 papers on this subject 2025: 59 of every 10,000 papers on this subject ▲ +6% share 2022→2025 share of research on this subject Caenorhabditis elegans · Longevity · Drosophila melanogaster · Drosophila
“Lysosomal signaling molecules regulate longevity in <i>Caenorhabditis elegans</i>”
Opportunities · theme 07
Longevity / Fecundity
555 papers · 9.2% of this block
2022: 75 of every 10,000 papers on this subject 2023: 64 of every 10,000 papers on this subject 2024: 59 of every 10,000 papers on this subject 2025: 57 of every 10,000 papers on this subject 2022: 75 of every 10,000 papers on this subject 2023: 64 of every 10,000 papers on this subject 2024: 59 of every 10,000 papers on this subject 2025: 57 of every 10,000 papers on this subject ▼ -24% share 2022→2025 share of research on this subject Longevity · Fecundity · Honey bee · Larva
“More on seed longevity phenotyping”
Which of these themes are growing fastest Tracks how the share of research themes has shifted worldwide between 2022 and 2025.
Problems
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining share losing share
Immune System / Disease ▲+1%
Reproduction / Fecundity ▼-4%
Gerontology / Longevity ▼-24%
Demography / Life Expectancy ▼-25%
Longevity / Longevity Risk ▼-30%
Longevity / Internal Medicine ▼-38%
Senescence / Cellular Senescence ▼-40%
Cautions
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining share losing share
Honey Bee / Pesticide ▼-7%
Longevity / Gerontology ▼-25%
Senescence / Cell Biology ▼-31%
Senescence / Mesenchymal Stem Cell ▼-37%
Longevity / Caenorhabditis Elegans ▼-37%
Internal Medicine / Calorie Restriction ▼-38%
Longevity / Fecundity ▼-43%
Opportunities
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining share losing share
Caenorhabditis Elegans / Longevity ▲+6%
Cancer Research / Cancer ▼-19%
Longevity / Fecundity ▼-24%
Longevity / Gerontology ▼-25%
Senescence / Autophagy ▼-33%
Senescence / Cell Biology ▼-36%
Senescence / Cell Biology ▼-40%
Prism
Go deeper on Age Tech and Longevity research and innovation
Research themes, patent activity and the companies commercialising them, in one place.
More landscapes
Keep going
Track Age Tech and Longevity in the United States beyond this page
Radar finds and filters the companies. Prism watches what is being said about them.
About this data: built from Fliar's company, founder, funding, hiring, jobs and research trackers, covering the United States. Counts are of companies we track, not of every company that exists. Updated September 2026.
Contact details
Reach this founder through Fliar Radar
Direct contact details for the people on this page are held in Fliar Radar, behind its own access controls.